Click for best price
IntravenousIV Therapy Vein Access Market Size, Share 2024
| Market size in 2023 |
US$ 33640 million
|
Forecast Market size by 2030 |
US$ 44300 million
|
| Growth Rate |
CAGR of 3.6% |
Number of Pages |
90 Pages |
This research report provides a comprehensive analysis of the Intravenous(IV) Therapy and Vein Access market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Intravenous(IV) Therapy and Vein Access market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Intravenous(IV) Therapy and Vein Access, challenges faced by the industry, and potential opportunities for market players.
The global Intravenous(IV) Therapy and Vein Access market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Intravenous(IV) Therapy and Vein Access market presents opportunities for various stakeholders, including Hospital, Clinics. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Intravenous(IV) Therapy and Vein Access market. Additionally, the growing consumer demand present avenues for market expansion.
The global Intravenous(IV) Therapy and Vein Access market was valued at US$ 33640 million in 2023 and is projected to reach US$ 44300 million by 2030, at a CAGR of 3.6% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Intravenous(IV) Therapy and Vein Access market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Intravenous(IV) Therapy and Vein Access market.
Market Overview: The report provides a comprehensive overview of the Intravenous(IV) Therapy and Vein Access market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Infusion Pumps, Implantable Ports), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Intravenous(IV) Therapy and Vein Access market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Intravenous(IV) Therapy and Vein Access market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Intravenous(IV) Therapy and Vein Access market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Intravenous(IV) Therapy and Vein Access market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Intravenous(IV) Therapy and Vein Access market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Intravenous(IV) Therapy and Vein Access market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Intravenous(IV) Therapy and Vein Access, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Intravenous(IV) Therapy and Vein Access market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Intravenous(IV) Therapy and Vein Access market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Infusion Pumps
Implantable Ports
Intravenous Catheters
Hypodermic Needles
Other
Market segment by Application
Hospital
Clinics
Other
Global Intravenous(IV) Therapy and Vein Access Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
B. Braun
Baxter International
Becton Dickinson
C. R. Bard
Fresenius Kabi
Hospira(ICU Medical)
Medtronic
Smiths Group
Teleflex
Outline of Major Chapters:
Chapter 1: Introduces the definition of Intravenous(IV) Therapy and Vein Access, market overview.
Chapter 2: Global Intravenous(IV) Therapy and Vein Access market size in revenue.
Chapter 3: Detailed analysis of Intravenous(IV) Therapy and Vein Access company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Intravenous(IV) Therapy and Vein Access in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Intravenous(IV) Therapy and Vein Access Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 33640 million
|
| Forecast Market size by 2030 |
US$ 44300 million
|
| Growth Rate |
CAGR of 3.6% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
90 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Intravenous(IV) Therapy and Vein Access Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Intravenous(IV) Therapy and Vein Access Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Intravenous(IV) Therapy and Vein Access Overall Market Size
2.1 Global Intravenous(IV) Therapy and Vein Access Market Size: 2023 VS 2030
2.2 Global Intravenous(IV) Therapy and Vein Access Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Intravenous(IV) Therapy and Vein Access Players in Global Market
3.2 Top Global Intravenous(IV) Therapy and Vein Access Companies Ranked by Revenue
3.3 Global Intravenous(IV) Therapy and Vein Access Revenue by Companies
3.4 Top 3 and Top 5 Intravenous(IV) Therapy and Vein Access Companies in Global Market, by Revenue in 2023
3.5 Global Companies Intravenous(IV) Therapy and Vein Access Product Type
3.6 Tier 1, Tier 2 and Tier 3 Intravenous(IV) Therapy and Vein Access Players in Global Market
3.6.1 List of Global Tier 1 Intravenous(IV) Therapy and Vein Access Companies
3.6.2 List of Global Tier 2 and Tier 3 Intravenous(IV) Therapy and Vein Access Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Intravenous(IV) Therapy and Vein Access Market Size Markets, 2023 & 2030
4.1.2 Infusion Pumps
4.1.3 Implantable Ports
4.1.4 Intravenous Catheters
4.1.5 Hypodermic Needles
4.1.6 Other
4.2 By Type - Global Intravenous(IV) Therapy and Vein Access Revenue & Forecasts
4.2.1 By Type - Global Intravenous(IV) Therapy and Vein Access Revenue, 2019-2024
4.2.2 By Type - Global Intravenous(IV) Therapy and Vein Access Revenue, 2025-2030
4.2.3 By Type - Global Intravenous(IV) Therapy and Vein Access Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Intravenous(IV) Therapy and Vein Access Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Other
5.2 By Application - Global Intravenous(IV) Therapy and Vein Access Revenue & Forecasts
5.2.1 By Application - Global Intravenous(IV) Therapy and Vein Access Revenue, 2019-2024
5.2.2 By Application - Global Intravenous(IV) Therapy and Vein Access Revenue, 2025-2030
5.2.3 By Application - Global Intravenous(IV) Therapy and Vein Access Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Intravenous(IV) Therapy and Vein Access Market Size, 2023 & 2030
6.2 By Region - Global Intravenous(IV) Therapy and Vein Access Revenue & Forecasts
6.2.1 By Region - Global Intravenous(IV) Therapy and Vein Access Revenue, 2019-2024
6.2.2 By Region - Global Intravenous(IV) Therapy and Vein Access Revenue, 2025-2030
6.2.3 By Region - Global Intravenous(IV) Therapy and Vein Access Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Intravenous(IV) Therapy and Vein Access Revenue, 2019-2030
6.3.2 US Intravenous(IV) Therapy and Vein Access Market Size, 2019-2030
6.3.3 Canada Intravenous(IV) Therapy and Vein Access Market Size, 2019-2030
6.3.4 Mexico Intravenous(IV) Therapy and Vein Access Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Intravenous(IV) Therapy and Vein Access Revenue, 2019-2030
6.4.2 Germany Intravenous(IV) Therapy and Vein Access Market Size, 2019-2030
6.4.3 France Intravenous(IV) Therapy and Vein Access Market Size, 2019-2030
6.4.4 U.K. Intravenous(IV) Therapy and Vein Access Market Size, 2019-2030
6.4.5 Italy Intravenous(IV) Therapy and Vein Access Market Size, 2019-2030
6.4.6 Russia Intravenous(IV) Therapy and Vein Access Market Size, 2019-2030
6.4.7 Nordic Countries Intravenous(IV) Therapy and Vein Access Market Size, 2019-2030
6.4.8 Benelux Intravenous(IV) Therapy and Vein Access Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Intravenous(IV) Therapy and Vein Access Revenue, 2019-2030
6.5.2 China Intravenous(IV) Therapy and Vein Access Market Size, 2019-2030
6.5.3 Japan Intravenous(IV) Therapy and Vein Access Market Size, 2019-2030
6.5.4 South Korea Intravenous(IV) Therapy and Vein Access Market Size, 2019-2030
6.5.5 Southeast Asia Intravenous(IV) Therapy and Vein Access Market Size, 2019-2030
6.5.6 India Intravenous(IV) Therapy and Vein Access Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Intravenous(IV) Therapy and Vein Access Revenue, 2019-2030
6.6.2 Brazil Intravenous(IV) Therapy and Vein Access Market Size, 2019-2030
6.6.3 Argentina Intravenous(IV) Therapy and Vein Access Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Intravenous(IV) Therapy and Vein Access Revenue, 2019-2030
6.7.2 Turkey Intravenous(IV) Therapy and Vein Access Market Size, 2019-2030
6.7.3 Israel Intravenous(IV) Therapy and Vein Access Market Size, 2019-2030
6.7.4 Saudi Arabia Intravenous(IV) Therapy and Vein Access Market Size, 2019-2030
6.7.5 UAE Intravenous(IV) Therapy and Vein Access Market Size, 2019-2030
7 Intravenous(IV) Therapy and Vein Access Companies Profiles
7.1 B. Braun
7.1.1 B. Braun Company Summary
7.1.2 B. Braun Business Overview
7.1.3 B. Braun Intravenous(IV) Therapy and Vein Access Major Product Offerings
7.1.4 B. Braun Intravenous(IV) Therapy and Vein Access Revenue in Global Market (2019-2024)
7.1.5 B. Braun Key News & Latest Developments
7.2 Baxter International
7.2.1 Baxter International Company Summary
7.2.2 Baxter International Business Overview
7.2.3 Baxter International Intravenous(IV) Therapy and Vein Access Major Product Offerings
7.2.4 Baxter International Intravenous(IV) Therapy and Vein Access Revenue in Global Market (2019-2024)
7.2.5 Baxter International Key News & Latest Developments
7.3 Becton Dickinson
7.3.1 Becton Dickinson Company Summary
7.3.2 Becton Dickinson Business Overview
7.3.3 Becton Dickinson Intravenous(IV) Therapy and Vein Access Major Product Offerings
7.3.4 Becton Dickinson Intravenous(IV) Therapy and Vein Access Revenue in Global Market (2019-2024)
7.3.5 Becton Dickinson Key News & Latest Developments
7.4 C. R. Bard
7.4.1 C. R. Bard Company Summary
7.4.2 C. R. Bard Business Overview
7.4.3 C. R. Bard Intravenous(IV) Therapy and Vein Access Major Product Offerings
7.4.4 C. R. Bard Intravenous(IV) Therapy and Vein Access Revenue in Global Market (2019-2024)
7.4.5 C. R. Bard Key News & Latest Developments
7.5 Fresenius Kabi
7.5.1 Fresenius Kabi Company Summary
7.5.2 Fresenius Kabi Business Overview
7.5.3 Fresenius Kabi Intravenous(IV) Therapy and Vein Access Major Product Offerings
7.5.4 Fresenius Kabi Intravenous(IV) Therapy and Vein Access Revenue in Global Market (2019-2024)
7.5.5 Fresenius Kabi Key News & Latest Developments
7.6 Hospira(ICU Medical)
7.6.1 Hospira(ICU Medical) Company Summary
7.6.2 Hospira(ICU Medical) Business Overview
7.6.3 Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Major Product Offerings
7.6.4 Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Revenue in Global Market (2019-2024)
7.6.5 Hospira(ICU Medical) Key News & Latest Developments
7.7 Medtronic
7.7.1 Medtronic Company Summary
7.7.2 Medtronic Business Overview
7.7.3 Medtronic Intravenous(IV) Therapy and Vein Access Major Product Offerings
7.7.4 Medtronic Intravenous(IV) Therapy and Vein Access Revenue in Global Market (2019-2024)
7.7.5 Medtronic Key News & Latest Developments
7.8 Smiths Group
7.8.1 Smiths Group Company Summary
7.8.2 Smiths Group Business Overview
7.8.3 Smiths Group Intravenous(IV) Therapy and Vein Access Major Product Offerings
7.8.4 Smiths Group Intravenous(IV) Therapy and Vein Access Revenue in Global Market (2019-2024)
7.8.5 Smiths Group Key News & Latest Developments
7.9 Teleflex
7.9.1 Teleflex Company Summary
7.9.2 Teleflex Business Overview
7.9.3 Teleflex Intravenous(IV) Therapy and Vein Access Major Product Offerings
7.9.4 Teleflex Intravenous(IV) Therapy and Vein Access Revenue in Global Market (2019-2024)
7.9.5 Teleflex Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Intravenous(IV) Therapy and Vein Access Market Opportunities & Trends in Global Market
Table 2. Intravenous(IV) Therapy and Vein Access Market Drivers in Global Market
Table 3. Intravenous(IV) Therapy and Vein Access Market Restraints in Global Market
Table 4. Key Players of Intravenous(IV) Therapy and Vein Access in Global Market
Table 5. Top Intravenous(IV) Therapy and Vein Access Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Intravenous(IV) Therapy and Vein Access Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Intravenous(IV) Therapy and Vein Access Revenue Share by Companies, 2019-2024
Table 8. Global Companies Intravenous(IV) Therapy and Vein Access Product Type
Table 9. List of Global Tier 1 Intravenous(IV) Therapy and Vein Access Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Intravenous(IV) Therapy and Vein Access Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Intravenous(IV) Therapy and Vein Access Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Intravenous(IV) Therapy and Vein Access Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Intravenous(IV) Therapy and Vein Access Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Intravenous(IV) Therapy and Vein Access Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Intravenous(IV) Therapy and Vein Access Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Intravenous(IV) Therapy and Vein Access Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2025-2030
Table 30. B. Braun Company Summary
Table 31. B. Braun Intravenous(IV) Therapy and Vein Access Product Offerings
Table 32. B. Braun Intravenous(IV) Therapy and Vein Access Revenue (US$, Mn) & (2019-2024)
Table 33. B. Braun Key News & Latest Developments
Table 34. Baxter International Company Summary
Table 35. Baxter International Intravenous(IV) Therapy and Vein Access Product Offerings
Table 36. Baxter International Intravenous(IV) Therapy and Vein Access Revenue (US$, Mn) & (2019-2024)
Table 37. Baxter International Key News & Latest Developments
Table 38. Becton Dickinson Company Summary
Table 39. Becton Dickinson Intravenous(IV) Therapy and Vein Access Product Offerings
Table 40. Becton Dickinson Intravenous(IV) Therapy and Vein Access Revenue (US$, Mn) & (2019-2024)
Table 41. Becton Dickinson Key News & Latest Developments
Table 42. C. R. Bard Company Summary
Table 43. C. R. Bard Intravenous(IV) Therapy and Vein Access Product Offerings
Table 44. C. R. Bard Intravenous(IV) Therapy and Vein Access Revenue (US$, Mn) & (2019-2024)
Table 45. C. R. Bard Key News & Latest Developments
Table 46. Fresenius Kabi Company Summary
Table 47. Fresenius Kabi Intravenous(IV) Therapy and Vein Access Product Offerings
Table 48. Fresenius Kabi Intravenous(IV) Therapy and Vein Access Revenue (US$, Mn) & (2019-2024)
Table 49. Fresenius Kabi Key News & Latest Developments
Table 50. Hospira(ICU Medical) Company Summary
Table 51. Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Product Offerings
Table 52. Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Revenue (US$, Mn) & (2019-2024)
Table 53. Hospira(ICU Medical) Key News & Latest Developments
Table 54. Medtronic Company Summary
Table 55. Medtronic Intravenous(IV) Therapy and Vein Access Product Offerings
Table 56. Medtronic Intravenous(IV) Therapy and Vein Access Revenue (US$, Mn) & (2019-2024)
Table 57. Medtronic Key News & Latest Developments
Table 58. Smiths Group Company Summary
Table 59. Smiths Group Intravenous(IV) Therapy and Vein Access Product Offerings
Table 60. Smiths Group Intravenous(IV) Therapy and Vein Access Revenue (US$, Mn) & (2019-2024)
Table 61. Smiths Group Key News & Latest Developments
Table 62. Teleflex Company Summary
Table 63. Teleflex Intravenous(IV) Therapy and Vein Access Product Offerings
Table 64. Teleflex Intravenous(IV) Therapy and Vein Access Revenue (US$, Mn) & (2019-2024)
Table 65. Teleflex Key News & Latest Developments
List of Figures
Figure 1. Intravenous(IV) Therapy and Vein Access Segment by Type in 2023
Figure 2. Intravenous(IV) Therapy and Vein Access Segment by Application in 2023
Figure 3. Global Intravenous(IV) Therapy and Vein Access Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Intravenous(IV) Therapy and Vein Access Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Intravenous(IV) Therapy and Vein Access Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Intravenous(IV) Therapy and Vein Access Revenue in 2023
Figure 8. By Type - Global Intravenous(IV) Therapy and Vein Access Revenue Market Share, 2019-2030
Figure 9. By Application - Global Intravenous(IV) Therapy and Vein Access Revenue Market Share, 2019-2030
Figure 10. By Type - Global Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Intravenous(IV) Therapy and Vein Access Revenue Market Share, 2019-2030
Figure 12. By Application - Global Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Intravenous(IV) Therapy and Vein Access Revenue Market Share, 2019-2030
Figure 14. By Region - Global Intravenous(IV) Therapy and Vein Access Revenue Market Share, 2019-2030
Figure 15. By Country - North America Intravenous(IV) Therapy and Vein Access Revenue Market Share, 2019-2030
Figure 16. US Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Intravenous(IV) Therapy and Vein Access Revenue Market Share, 2019-2030
Figure 20. Germany Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2030
Figure 21. France Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Intravenous(IV) Therapy and Vein Access Revenue Market Share, 2019-2030
Figure 28. China Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2030
Figure 32. India Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Intravenous(IV) Therapy and Vein Access Revenue Market Share, 2019-2030
Figure 34. Brazil Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Intravenous(IV) Therapy and Vein Access Revenue Market Share, 2019-2030
Figure 37. Turkey Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Intravenous(IV) Therapy and Vein Access Revenue, (US$, Mn), 2019-2030
Figure 41. B. Braun Intravenous(IV) Therapy and Vein Access Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Baxter International Intravenous(IV) Therapy and Vein Access Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Becton Dickinson Intravenous(IV) Therapy and Vein Access Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. C. R. Bard Intravenous(IV) Therapy and Vein Access Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Fresenius Kabi Intravenous(IV) Therapy and Vein Access Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Medtronic Intravenous(IV) Therapy and Vein Access Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Smiths Group Intravenous(IV) Therapy and Vein Access Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Teleflex Intravenous(IV) Therapy and Vein Access Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
